Biovitrum acquires promising anti-obesity drug leads from BioFocus
24-Sep-2004 -
Chesterford Research Park, UK and Stockholm, Sweden. BioFocus plc., a world leader in drug discovery, and Biovitrum today announce that Biovitrum has acquired from BioFocus the rights to a promising research project in obesity. The research project, which currently is at the end of the lead ...
atherosclerosis
Biovitrum
business development
+9